Badri N. Dasu - 06 Feb 2022 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (TLPH)

Role
Chief Engineering Officer
Signature
/s/ Martha Adler, Attorney-In-Fact
Issuer symbol
TLPH
Transactions as of
06 Feb 2022
Net transactions value
-$2,945
Form type
4
Filing time
07 Feb 2022, 19:19:09 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Tax liability $2,945 -6,830 -3.2% $0.4312 204,322 06 Feb 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F3 Balance includes non-reportable acquisition of 6,395 shares of Common Stock through the Company's Employee Stock Purchase Plan.